GSK-2330811 is a humanized IgG1 antibody targeting oncostatin M (OSM). It holds potential for studying diffuse systemic sclerosis. For the isotype control of GSK-2330811, refer to Human IgG1 kappa, Isotype Control.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
